Figure 1. Age-specific prevalence of sarcopenia in men, women and subjects overall at the 2012 and 2017 surveys. Values on each bar are shown as the age-specific prevalence (95% confidence interval). The maximum gait speed was used for estimating sarcopenia. *P < 0.05 vs 65–69 years in each survey. There was no evidence of a significant difference in the age-specific prevalence of sarcopenia between surveys for all age categories in men, women, or subjects overall (all P > 0.12).
